Liege, Belgium – 09 September 2026 (08:30 CET) – Allegro NV, a biomedical company developing a transformative nanotechnology treatment for osteoarthritis, today […]
Allegro rapporteert bemoedigende klinische resultaten met gepatenteerde injecteerbare nanotechnologie voor knieartrose • Hydrocelin werd inmiddels geëvalueerd bij 50 patiënten met knieartrose, waaronder […]
Allegro updated this press release on April 20, 2026, to refine certain statements in accordance with regulatory guidelines Liege, Belgium – 12 […]
Liege, Belgium – 9 January 2026 (08:30 CET) – Allegro NV, a biomedical company developing transformative injectable, mechanically-acting devices for osteoarthritis, will […]
Liege, Belgium and Shirley, NY – 25 November 2025 (08:30 CET) – Allegro NV, a biomedical company developing transformative nanotechnology-based devices for […]
Allegro updated this press release on April 20, 2026, to refine certain statements in accordance with regulatory guidelines Liege, Belgium – 7 […]
Allegro was featured in the Noshaq Stories this month with a full feature article in French. Read the full article below or […]
Liège 17 February 2025 – Allegro, a pioneering biomedical company from Belgium, has won the prestigious Companion Animals Prize for its hydrocelin […]
Allegro is Heading to the Biotech Showcase in San Francisco! We’re excited to announce that Allegro will be attending the Biotech Showcase […]
We are thrilled to announce that Allegro has won 3rd prize at the prestigious HealthTech Innovation Days (HTID) event in Paris! The […]